Eileen Burd
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 1%
Papers in
-
- Antimicrobial Resistance in Staphylococcus 9
-
- Antibiotic Resistance in Bacteria 19
- Co-authors
- David S. Weiss (13 shared papers)Craig M. Coopersmith (30 shared papers)Lars F. Westblade (8 shared papers)Zhe Liang (26 shared papers)W. Michael Dunne (5 shared papers)Colleen S. Kraft (20 shared papers)Laurent Poirel (1 shared paper)John Maynard Conly (1 shared paper)
- Journals
- Journal of Clinical Microbiology (31 papers)Shock (12 papers)PLoS ONE (6 papers)mBio (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)
- Partner nations
- United StatesSaudi ArabiaChina
In The Last Decade
Eileen Burd
141 papers receiving 6.9k citations
Eileen Burd's Hit Papers
Peers
Comparison fields: 5 of 165
- Molecular Medicine 1.2k
- Endocrinology 475
- Applied Microbiology and Biotechnology 153
- Epidemiology 2.5k
- Clinical Biochemistry 436
Countries citing papers authored by Eileen Burd
This map shows the geographic impact of Eileen Burd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Burd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Burd more than expected).
Fields of papers citing papers by Eileen Burd
This network shows the impact of papers produced by Eileen Burd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Burd. The network helps show where Eileen Burd may publish in the future.
Co-authors
The 25 scholars most cited alongside Eileen Burd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human Papillomavirus and Cervical Cancer Hit paper breakdown → | 2003 | 1898 |
| 2 | Carbapenemase-Producing Organisms: A Global Scourge Hit paper breakdown → | 2017 | 492 |
| 3 | 2010 | 424 | |
| 4 | 1993 | 221 | |
| 5 | 2016 | 211 | |
| 6 | 2016 | 191 | |
| 7 | 2012 | 182 | |
| 8 | 2016 | 139 | |
| 9 | 2019 | 131 | |
| 10 | 2018 | 125 | |
| 11 | 2018 | 113 | |
| 12 | 2018 | 112 | |
| 13 | 2017 | 111 | |
| 14 | 2018 | 105 | |
| 15 | 1983 | 103 | |
| 16 | 2013 | 96 | |
| 17 | 2013 | 95 | |
| 18 | 2023 | 81 | |
| 19 | 2019 | 76 | |
| 20 | 2015 | 75 |
About Eileen Burd
Eileen Burd is a scholar working on Infectious Diseases, Molecular Medicine, Epidemiology, Endocrinology and Clinical Biochemistry, having authored 143 papers that have together received 7.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (19 papers), Bacterial Identification and Susceptibility Testing (16 papers), Immune Response and Inflammation (13 papers), Ocular Infections and Treatments (9 papers), Bacterial biofilms and quorum sensing (9 papers), Sepsis Diagnosis and Treatment (9 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Gut microbiota and health (8 papers). The work is most often cited by research in Molecular Medicine (1.2k citations), Endocrinology (475 citations), Applied Microbiology and Biotechnology (153 citations), Epidemiology (2.5k citations) and Clinical Biochemistry (436 citations). Eileen Burd has collaborated with scholars based in United States, Saudi Arabia and China. Frequent co-authors include David S. Weiss, Craig M. Coopersmith, Lars F. Westblade, Zhe Liang, W. Michael Dunne, Colleen S. Kraft, Laurent Poirel, John Maynard Conly, Julie A. Segre and Robert A. Bonomo. Their work appears in journals such as Journal of Clinical Microbiology, Shock, PLoS ONE, mBio and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.